Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

A Comparison of Two Urinary Catheters of Different Lengths for Female Use, in Intermittent Catheterization

26 апреля 2021 г. обновлено: Wellspect HealthCare

A Multi Centre, Single-blind, Randomized, Cross-over Study Comparing Two Female Catheters With Different Length in Terms of Residual Urine After Intermittent Catheterization

A study comparing a 10 cm catheter with a 7 cm catheter in a group of female patients who, on a routine bases, empty their bladder using urinary catheters, by measuring residual urine after intermittent catheterization.

Обзор исследования

Статус

Завершенный

Подробное описание

The study personnel will conduct three bladder scans after each catheterization in order to obtain the mean residual urine volume. Each patient will catheterize herself two times with each product, i.e. a total of four catheterizations.

Diagnosis and BMI will be collected at visit 1 to assess whether the residual urine volume differs between these subgroups.

The hypothesis that the mean residual volumes were equal when using the 7 and the 10 centimeter catheters was tested by means of the Wilcoxon signed rank test.

Тип исследования

Интервенционный

Регистрация (Действительный)

60

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Места учебы

      • Borås, Швеция, SE-501 82
        • Rehabiliteringskliniken, Södra Älvsborgs Sjukhus
      • Gothenburg, Швеция, SE-413 45
        • Verksamhet Urologi, Sahlgrenska Universitetssjukhuset
      • Lund, Швеция, SE-221 85
        • Clinical Research and Trial Centre, Lund University Hospital

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

18 лет и старше (Взрослый, Пожилой взрослый)

Принимает здоровых добровольцев

Нет

Полы, имеющие право на обучение

Женский

Описание

Inclusion Criteria:

  • Provision of signed informed consent
  • Female subjects aged 18 years and over
  • Experienced users of CIC with a minimum of one month of use
  • Practice CIC a minimum of 1 time per day
  • Practice CIC with female catheters with a maximum length of 20 cm
  • Perform self-catheterization
  • Sufficient hand function to be able to open and handle catheter packages
  • Use catheters with Ch 10, 12 or 14

Exclusion Criteria:

  • Pregnancy
  • Ongoing symptomatic UTI
  • Involvement in the planning and conduct of the study (applies to both Astra Tech staff or staff at the study site)
  • Previous enrolment or randomisation of treatment in the present study
  • Participation in another clinical study during the study period
  • Severe non-compliance to protocol as judged by the investigator and/or Astra Tech

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Другой
  • Распределение: Рандомизированный
  • Интервенционная модель: Назначение кроссовера
  • Маскировка: Двойной

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: AABB

A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 7 cm then 7 cm then 10 cm then 10 cm

Four catheterizations in total, two catheterizations with each study product in a randomized order.

Catheterization should resemble the daily use as far as possible and at least 2 hours had to pass between 2 catheterizations.The study centre decided whether the subject performed all four catheterizations on one or several days.
Другие имена:
  • Coloplast SpeediCath Compact 7 cm
  • Astra Tech POBE 10 cm
Экспериментальный: ABAB

A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 7 cm then 10 cm then 7 cm then 10 cm

Four catheterizations in total, two catheterizations with each study product in a randomized order.

Catheterization should resemble the daily use as far as possible and at least 2 hours had to pass between 2 catheterizations.The study centre decided whether the subject performed all four catheterizations on one or several days.
Другие имена:
  • Coloplast SpeediCath Compact 7 cm
  • Astra Tech POBE 10 cm
Экспериментальный: ABBA

A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 7 cm then 10 cm then 10 cm then 7 cm

Four catheterizations in total, two catheterizations with each study product in a randomized order.

Catheterization should resemble the daily use as far as possible and at least 2 hours had to pass between 2 catheterizations.The study centre decided whether the subject performed all four catheterizations on one or several days.
Другие имена:
  • Coloplast SpeediCath Compact 7 cm
  • Astra Tech POBE 10 cm
Экспериментальный: BAAB

A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 10 cm then 7 cm then 7 cm then 10 cm

Four catheterizations in total, two catheterizations with each study product in a randomized order.

Catheterization should resemble the daily use as far as possible and at least 2 hours had to pass between 2 catheterizations.The study centre decided whether the subject performed all four catheterizations on one or several days.
Другие имена:
  • Coloplast SpeediCath Compact 7 cm
  • Astra Tech POBE 10 cm
Экспериментальный: BABA

A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 10 cm then then 7 cm then 10 cm then 7 cm

Four catheterizations in total, two catheterizations with each study product in a randomized order.

Catheterization should resemble the daily use as far as possible and at least 2 hours had to pass between 2 catheterizations.The study centre decided whether the subject performed all four catheterizations on one or several days.
Другие имена:
  • Coloplast SpeediCath Compact 7 cm
  • Astra Tech POBE 10 cm
Экспериментальный: BBAA

A=Coloplast SpeediCath Compact catheter, 7 cm B=Astra Tech POBE catheter, 10 cm 10 cm then 10 cm then 7 cm then 7 cm

Four catheterizations in total, two catheterizations with each study product in a randomized order.

Catheterization should resemble the daily use as far as possible and at least 2 hours had to pass between 2 catheterizations.The study centre decided whether the subject performed all four catheterizations on one or several days.
Другие имена:
  • Coloplast SpeediCath Compact 7 cm
  • Astra Tech POBE 10 cm

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Bladder Scan Measurements of Residual Urine Volume
Временное ограничение: Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.

Measurements were performed with the bladder scan BVI 3000. The primary outcome variable was average residual urine volume (mL) calculated from repetitive bladder scans performed after each catheterization.

Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated.

Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Number of Subjects With a Residual Volume >5mL or ≤5mL
Временное ограничение: Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. At least 2 hours had to pass between 2 catheterizations.
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. At least 2 hours had to pass between 2 catheterizations.
Number of Subjects With a Residual Volume >10mL or ≤10mL
Временное ограничение: Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Number of Subjects With a Residual Volume >30mL or ≤30mL
Временное ограничение: Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Number of Subjects With a Residual Volume >50mL or ≤50mL
Временное ограничение: Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Three bladder scan measurements were performed immediately after each catheterization and a mean value was calculated. A maximum of 5 minutes were allowed to elapse between catheterization and bladder scan.
Does the Subject's Bladder Feel Completely Empty After Catheterisation (All Subjects)
Временное ограничение: Question asked minutes after catheterization.

After each catheterization the study nurse will ask the subject whether it feels as if the bladder is completely emptied or not.

0=No and 1=Yes.

Question asked minutes after catheterization.

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Спонсор

Следователи

  • Главный следователь: Ulf Malmqvist, MD, PhD, Assoc.Prof., Clinical Research and Trial Centre, Lund University Hospital

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Действительный)

1 ноября 2008 г.

Первичное завершение (Действительный)

1 января 2009 г.

Завершение исследования (Действительный)

1 марта 2009 г.

Даты регистрации исследования

Первый отправленный

28 ноября 2008 г.

Впервые представлено, что соответствует критериям контроля качества

28 ноября 2008 г.

Первый опубликованный (Оценивать)

1 декабря 2008 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

18 мая 2021 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

26 апреля 2021 г.

Последняя проверка

1 апреля 2021 г.

Дополнительная информация

Термины, связанные с этим исследованием

Другие идентификационные номера исследования

  • YA-LOF-0015

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

продукт, произведенный в США и экспортированный из США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться